Barrett Katz serves as Executive at Viridian Therapeutics, Inc.\DE, where they oversee executive responsibilities. Since joining the company, Barrett Katz has executed 8 insider transactions totaling $3.2M, demonstrating a bearish approach to their equity position. Their most recent transaction on Jan 17, 2023 involved selling 24,853 shares valued at $924.8K.
Barrett Katz currently holds 24,853 shares of Viridian Therapeutics, Inc.\DE (VRDN), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Barrett Katz has been a net seller of VRDN stock. They have purchased $0 and sold $3.2M worth of shares.
Barrett Katz's most recent insider trade was on Jan 17, 2023, when they sold 24,853 shares at $37.21 per share.
Get notified when new Form 4 filings are submitted
| $23.03 |
| Discretionary |
| Jan 13, 2023 | VRDN | $153.5K | Sale | 4,147 | $37.01 | Discretionary |
| Jan 13, 2023 | VRDN | $95.5K | Option Exercise | 4,147 | $23.03 | Discretionary |
| Jan 10, 2023 | VRDN | $1.7M | Sale | 47,377 | $35.30 | Discretionary |
| Jan 10, 2023 | VRDN | $1.1M | Option Exercise | 47,377 | $23.03 | Discretionary |
| Jan 9, 2023 | VRDN | $417.1K | Sale | 12,623 | $33.04 | Discretionary |
| Jan 9, 2023 | VRDN | $290.7K | Option Exercise | 12,623 | $23.03 | Discretionary |